OVERSEA CHINESE BANKING Corp Ltd Acquires New Position in CME Group Inc. (NASDAQ:CME)

OVERSEA CHINESE BANKING Corp Ltd bought a new position in CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,526 shares of the financial services provider’s stock, valued at approximately $337,000.

Several other institutional investors also recently bought and sold shares of the business. Y.D. More Investments Ltd purchased a new stake in CME Group in the second quarter valued at approximately $36,000. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares during the last quarter. Asset Dedication LLC raised its position in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after buying an additional 170 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares during the last quarter. Finally, Bank & Trust Co purchased a new stake in CME Group during the second quarter valued at about $76,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Up 0.8 %

CME stock opened at $228.14 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a 50 day simple moving average of $222.20 and a 200-day simple moving average of $210.04. The company has a market capitalization of $82.15 billion, a P/E ratio of 23.99, a PEG ratio of 5.69 and a beta of 0.55. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $230.36.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the firm earned $2.25 EPS. The company’s revenue was up 18.4% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is presently 48.37%.

Analysts Set New Price Targets

A number of research firms have recently commented on CME. Citigroup raised their price objective on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. TD Cowen began coverage on shares of CME Group in a research report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target on the stock. Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Finally, Bank of America increased their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, CME Group currently has a consensus rating of “Hold” and an average price target of $224.47.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.